Peter D. Gorycki

938 total citations
29 papers, 735 citations indexed

About

Peter D. Gorycki is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Peter D. Gorycki has authored 29 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Peter D. Gorycki's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Peter D. Gorycki is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Peter D. Gorycki collaborates with scholars based in United States, United Kingdom and Australia. Peter D. Gorycki's co-authors include Edward F. Webb, Don E. Griswold, Theodore J. Torphy, Jan G. Hengstler, Paul Skett, José M. Silva, Gregory L. Kedderis, Albert P. Li, Yanli Deng and H.G. Koebe and has published in prestigious journals such as Nucleic Acids Research, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Peter D. Gorycki

29 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter D. Gorycki United States 13 344 166 146 116 102 29 735
Xiaojuan Xiao China 19 454 1.3× 224 1.3× 134 0.9× 114 1.0× 44 0.4× 55 1.0k
Tanya Coleman United Kingdom 17 589 1.7× 282 1.7× 147 1.0× 115 1.0× 44 0.4× 28 1.1k
Anne Cooper United Kingdom 13 155 0.5× 211 1.3× 67 0.5× 69 0.6× 59 0.6× 20 724
N.R. Kitteringham United Kingdom 20 281 0.8× 250 1.5× 46 0.3× 345 3.0× 58 0.6× 33 971
Robert A. Galemmo United States 19 494 1.4× 158 1.0× 262 1.8× 32 0.3× 39 0.4× 46 1.0k
Patrick Brassil United States 18 548 1.6× 272 1.6× 214 1.5× 189 1.6× 39 0.4× 28 1.2k
Pamela K. Smitherman United States 18 652 1.9× 327 2.0× 67 0.5× 93 0.8× 119 1.2× 20 1.0k
Martin Wurm Austria 12 364 1.1× 233 1.4× 45 0.3× 187 1.6× 20 0.2× 20 861
Christina Lamers Germany 16 494 1.4× 193 1.2× 175 1.2× 47 0.4× 35 0.3× 30 961
Emile G. Plise United States 17 493 1.4× 312 1.9× 77 0.5× 115 1.0× 31 0.3× 39 876

Countries citing papers authored by Peter D. Gorycki

Since Specialization
Citations

This map shows the geographic impact of Peter D. Gorycki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Gorycki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Gorycki more than expected).

Fields of papers citing papers by Peter D. Gorycki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Gorycki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Gorycki. The network helps show where Peter D. Gorycki may publish in the future.

Co-authorship network of co-authors of Peter D. Gorycki

This figure shows the co-authorship network connecting the top 25 collaborators of Peter D. Gorycki. A scholar is included among the top collaborators of Peter D. Gorycki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter D. Gorycki. Peter D. Gorycki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Miao, Xiu‐Sheng, Gordon J. Dear, Claire Beaumont, et al.. (2024). Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity. Chemical Research in Toxicology. 37(5). 698–710. 3 indexed citations
3.
4.
Zhu, John, Chester L. Bowen, Odin Naderer, et al.. (2014). Investigation of Metabolism and Disposition of GSK1322322, a Peptidase Deformylase Inhibitor, in Healthy Humans Using the Entero-Test for Biliary Sampling. Drug Metabolism and Disposition. 42(8). 1314–1325. 9 indexed citations
5.
Ouellet, Danièle, Noelia Nebot, Stanley W. Carson, et al.. (2013). Metabolism and Disposition of Oral Dabrafenib in Cancer Patients: Proposed Participation of Aryl Nitrogen in Carbon-Carbon Bond Cleavage via Decarboxylation following Enzymatic Oxidation. Drug Metabolism and Disposition. 41(12). 2215–2224. 36 indexed citations
6.
Deng, Yanli, et al.. (2012). Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancer. Xenobiotica. 43(5). 443–453. 72 indexed citations
7.
Deng, Yanli, et al.. (2011). Investigations of Hydrazine Cleavage of Eltrombopag in Humans. Drug Metabolism and Disposition. 39(9). 1747–1754. 9 indexed citations
8.
Schubert, Ernest M., et al.. (2011). Metabolism of [14C]GSK977779 in Rats and Its Implication with the Observed Covalent Binding. Drug Metabolism and Disposition. 39(9). 1620–1632. 9 indexed citations
9.
Deng, Yanli, Mary Beth Wire, Carolyn J. Bowen, et al.. (2011). Metabolism and Disposition of Eltrombopag, an Oral, Nonpeptide Thrombopoietin Receptor Agonist, in Healthy Human Subjects. Drug Metabolism and Disposition. 39(9). 1734–1746. 38 indexed citations
10.
Palovich, Michael R., Katherine L. Widdowson, Miriam Burman, et al.. (2006). Comparison of N,N′-diarylsquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor. Bioorganic & Medicinal Chemistry Letters. 17(6). 1713–1717. 32 indexed citations
11.
Jin, Qi, Hong Nie, Katherine L. Widdowson, et al.. (2004). Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor. Bioorganic & Medicinal Chemistry Letters. 14(17). 4375–4378. 32 indexed citations
12.
Marquis, Robert W., Keith W. Ward, Theresa J. Roethke, et al.. (2003). An Azepanone-Based Inhibitor of Human Cathepsin K with Improved Oral Bioavailability in the Rat and the Monkey. Molecular Pharmaceutics. 1(1). 97–100. 6 indexed citations
13.
Ward, Katie, Joel W. Proksch, Peter D. Gorycki, et al.. (2002). SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. II: In vitro and in vivo metabolism studies and pharmacokinetic extrapolation to man. Xenobiotica. 32(3). 235–250. 11 indexed citations
14.
Li, Albert P., Peter D. Gorycki, Jan G. Hengstler, et al.. (1999). Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel. Chemico-Biological Interactions. 121(1). 117–123. 113 indexed citations
15.
Adams, Jerry L., Jeffrey C. Boehm, Shouki Kassis, et al.. (1998). Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes. Bioorganic & Medicinal Chemistry Letters. 8(22). 3111–3116. 88 indexed citations
16.
Underwood, David C., Steven Bochnowicz, Ruth R. Osborn, et al.. (1998). Antiasthmatic Activity of the Second-Generation Phosphodiesterase 4 (PDE4) Inhibitor SB 207499 (Ariflo) in the Guinea Pig. Journal of Pharmacology and Experimental Therapeutics. 287(3). 988–995. 60 indexed citations
17.
Gorycki, Peter D. & Timothy L. Macdonald. (1994). The Oxidation of Tetrasubstituted Alkenes by Cytochrome P450. Chemical Research in Toxicology. 7(6). 745–751. 4 indexed citations
18.
Gorycki, Peter D., et al.. (1990). The mechanism of aphidicolin bioinactivation by rat liver in vitro systems. Xenobiotica. 20(3). 273–287. 9 indexed citations
19.
Latham, Michael D., et al.. (1989). Inhibition of topoisomerases by fredericamycin A. Cancer Chemotherapy and Pharmacology. 24(3). 167–171. 26 indexed citations
20.
Prasad, G.V. Siva, et al.. (1989). Structure-activity relationships for the inhibition of DNA polymerase α by aphidicolln derivatives. Nucleic Acids Research. 17(15). 6339–6348. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojuan Xiao Breakdown of academic impact, for papers by Tanya Coleman Breakdown of academic impact, for papers by Anne Cooper Breakdown of academic impact, for papers by N.R. Kitteringham Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Patrick Brassil Breakdown of academic impact, for papers by Pamela K. Smitherman Breakdown of academic impact, for papers by Martin Wurm Breakdown of academic impact, for papers by Christina Lamers Breakdown of academic impact, for papers by Emile G. Plise
Rankless by CCL
2026